comparemela.com

Page 3 - மேட் மக்லீந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Foundry Announces Successful First-In-Human Procedure In Study Of Innovative Transcatheter Mitral Valve Repair Technology

Share this article Share this article MENLO PARK, Calif., Jan. 11, 2021 /PRNewswire/ The Foundry today announced the successful completion of the first-in-human procedure with the Half Moon Medical transcatheter mitral repair technology (TMVr) at Oregon Health and Science University (OHSU) as part of an FDA-approved early feasibility study. The first patient treated has been discharged from the hospital and is recovering as expected. The investigational Half Moon mitral valve repair device, developed through a unique partnership between Medtronic (NYSE:MDT) and The Foundry, is designed to restore function in a diseased mitral valve in patients with severe symptomatic mitral regurgitation (MR), a disease where blood leaks backwards within the heart due to the mitral valve s inability to close properly.

Elderberry demand soars as consumers seek an immunity boost

Share it As the coronavirus started to spread across the U.S. last year and consumers grew increasingly concerned about staying healthy, Uncle Matt s Organic wanted to develop a new beverage that would support the immune system. CEO Matt McLean said the drink company started to look into ingredients to enhance its popular organic orange juice. After researching, McLean said the team landed on elderberry because of its powerful bioflavonoids like quercetin, which some say has potential health benefits.  Elderberries are the deep purple fruit of the elderberry shrub and have a history of use in folk medicine for treating sicknesses like colds. Some experts have said the berries and flowers of elderberry are packed with antioxidants and vitamins that can boost the immune system and have the potential to tame inflammation, but studies have found that the effectiveness varies.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.